Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Solid Biosciences has reported Restructuring Costs for 3 years, with the latest figure at -$63000.0 in Q2 2023.

• Quarterly Restructuring Costs fell 104.14% year-over-year to -$63000.0 in Q2 2023, while the trailing twelve-month figure through Dec 2023 was $5.6 million (down 22.05% YoY) and the FY2023 annual result came in at -$63000.0, down 100.88% from the prior year.
• Restructuring Costs slipped to -$63000.0 in Q2 2023 per SLDB's latest filing, from $5.7 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $5.7 million in Q4 2022 and troughed at -$63000.0 in Q2 2023.
• A 3-year average of $2.3 million and a median of $1.7 million in 2020 frame the typical range for Restructuring Costs.
• The widest YoY moves for Restructuring Costs: up 104.14% in 2023, down 104.14% in 2023.
• Over 3 years, Restructuring Costs stood at $1.9 million in 2020, then soared by 191.05% to $5.7 million in 2022, then tumbled by 101.11% to -$63000.0 in 2023.
• According to Business Quant data, Restructuring Costs over the past three periods registered -$63000.0, $5.7 million, and $1.5 million for Q2 2023, Q4 2022, and Q2 2022 respectively.